SNY Stock Chart

SANOFI

 

SNY

bhowe bhowe IBB, W, Long , 8 months ago
IBB: IBB Biotechnology sector
153 0 2
IBB, W Long
IBB Biotechnology sector
IBB, the tracking stock for the Bio sector looks ready to regain its upward trajectory. With the RSI and %R at very oversold positions it may be ready. We recently had a bounce off the 200ma, There appears to be consolidation in the blue box currently. Look for a move above the 8ema to enter long.
WholeLottaBull WholeLottaBull PIRS, D, Long , 10 months ago
PIRS: Time to go long on PIRS, very long.
68 0 1
PIRS, D Long
Time to go long on PIRS, very long.
The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn NASDAQ:PIRS was hit pretty hard. This presents a true 10 bagger opportunity, and Im not even remotely stretching the truth. The technicals show you why right now is the ...
YoungMula YoungMula SNY, D, Short , 10 months ago
SNY: Potential Break Down ?
13 0 0
SNY, D Short
Potential Break Down ?
Target $36.50
YoungMula YoungMula SNY, W, 11 months ago
SNY: Potential Short?
14 0 1
SNY, W
Potential Short?
Short on a break of the uptrend line
Elemental Elemental AMGN, D, Long , 2 years ago
AMGN: Repatha will bring major volume and take AMGN to new heights.
227 4 1
AMGN, D Long
Repatha will bring major volume and take AMGN to new heights.
Repatha (AMGN) and Praluent (Regeneron (REGN)/Sinofy (SNY)) are two PCSK9 inhibitors, a new class of drugs to treat hypercholesterolemia more effectively than previously possible. This will trigger a HCV-like battle between the two as both have high efficacy. Both have room to share the market, allowing both to ...
daytraderrockstar daytraderrockstar PRO SNI, D, Long , 2 years ago
SNI: $SNI is now 68.35. Price Target Hit. Great Hps Trade
62 0 0
SNI, D Long
$SNI is now 68.35. Price Target Hit. Great Hps Trade
$SNI is now 68.35. Price Target Hit. Great Hps (High Probablity Setup ) Trade.
jangseohee jangseohee EFA, W, 2 years ago
EFA: EFA, please do not break the neckline again!!!
86 3 6
EFA, W
EFA, please do not break the neckline again!!!
The iShares MSCI EAFE ETF seeks to track the investment results of an index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. Top then holdings are Nestle (switzerland), Novartis (switzerland), Roche (switzerland), HSBC (UK), Toyota (Jpn), Shell (UK), Bayer AG ...
Verticalmojo Verticalmojo MNKD, D, Long , 2 years ago
MNKD: MNKD
267 0 2
MNKD, D Long
MNKD
Trend continuation, possible bullish outlook as long as price can stay above channel. MNKD (with partner Sanofi) is about to market and distribute FDA approved Afrezza, a inhaled insulin that can make insulin syringes a thing of the past. With diabetes a global condition that effects 371 million people ...
Wanna_Million Wanna_Million UNIS, D, Long , 2 years ago
UNIS: UNIS - Reversal - Is this the start of a meaningful uptrend?
127 0 0
UNIS, D Long
UNIS - Reversal - Is this the start of a meaningful uptrend?
Unilife recently announced an agreement with Sanofi to be the sole provider for a minimum of 15 years of cartridge based wearable injectors for all of Sanofi’s large dose volume drugs, excluding insulin. While the details are confidential, it is anticipated that it is for a "fast track" drug for high cholesterol, ...
Jakeccc Jakeccc REGN, D, Long , 2 years ago
REGN: If you've been waiting to get long REGN, now is the time.
46 0 2
REGN, D Long
If you've been waiting to get long REGN, now is the time.
It got beaten so badly because of some analyst's note saying that REGN's blockbuster eye drug Eylea has been replaced by cheaper rival drugs. First, it was only rumored to be "10%" of total patients, secondly, its rheumatoid arthritis drug "sarilumab" that is under development with Sanofi is showing promising signs ...
Jakeccc Jakeccc REGN, W, Long , 2 years ago
REGN: Regeneron Long-term Trend Remains Intact.
53 0 1
REGN, W Long
Regeneron Long-term Trend Remains Intact.
Many sector leaders like Gilead, Celgene, and Biogen all had a nice run up at the end of the week, which is encouraging given people tend to sell on Friday, especially in this market. This bad boy went berserk in April 2013, flied away from this trend line and entered into a channel, which by the way, it broke ...
BEI BEI SNY, M, Short , 3 years ago
SNY: SNY update
96 0 0
SNY, M Short
SNY update
Still the same from previous post, https://www.tradingview.com/v/fn8lDgyy/, that's the problem with SNY, so slow it's not always attractive. Supports should make - 65 / 66 in 10 dollars prices swings
daytraderrockstar daytraderrockstar PRO SNY, D, Long , 3 years ago
SNY: The most basic Pattern to Learn 1-2-3 Pattern
766 3 3
SNY, D Long
The most basic Pattern to Learn 1-2-3 Pattern
This is the foundation to many set ups. just like in anything you want to be great in you learn the basics and fundamentals. And great foundation will pay off
David_CMT_CFA David_CMT_CFA SNY, D, Long , 3 years ago
SNY: Long SNY
150 0 0
SNY, D Long
Long SNY
Big euro pharma Fibo confluence Indicators confirm Upside to 60ish

News

Fundamentals SNY

Price History
Average Volume ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Dividends
Dividends Paid ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Margins
After-tax Margin ---
Gross Margin ---
Gross Margin %, TTM ---
Operating Margin ---
Pre-tax Margin ---
Balance Sheet
Cash Ratio ---
Current Ratio ---
Debt to Assets ---
Debt to Equity ---
Long Term Capital ---
Net Debt ---
Quick Ratio ---
Total Assets ---
Total Capital ---
Total Debt ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA ---
Gross Profit ---
Last Annual EPS ---
Last Annual Revenue ---
Net Income ---
Total Revenue ---
Operating Metrics
Return on Assets ---
Return on Equity ---
Return on Invested Capital ---
Return on Invested Capital %, TTM ---
Revenue per Employee ---
Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out